We serve Chemical Name:(2-tert-butyl-4-methylcyclohexyl) acetate CAS:115724-27-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2-tert-butyl-4-methylcyclohexyl) acetate
CAS.NO:115724-27-1
Synonyms:2-tert-Butyl-4-methyl-cyclohexyl acetate;Damascate
Molecular Formula:C13H24O2
Molecular Weight:212.32800
HS Code:2915390090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:239.6ºC at 760mmHg
Density:0.92g/cm3
Index of Refraction:1.452
PSA:26.30000
Exact Mass:212.17800
LogP:3.40040
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-tert-Butyl-4-methyl-cyclohexyl acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Damascate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Damascate Use and application,2-tert-Butyl-4-methyl-cyclohexyl acetate technical grade,usp/ep/jp grade.
Related News: The CTSuccess service uses Catalent��s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics. (2-tert-butyl-4-methylcyclohexyl) acetate manufacturer Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. (2-tert-butyl-4-methylcyclohexyl) acetate supplier Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. (2-tert-butyl-4-methylcyclohexyl) acetate vendor The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI). (2-tert-butyl-4-methylcyclohexyl) acetate factory Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.
